Tarsus Pharmaceuticals, Inc.
TARSNasdaqCIK 1819790HealthcareFiscal year ends Dec 31
Reports and events: 104 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1320:00 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001819790-26-000069 |
| 2026-09-1020:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001819790-26-000066 |
| 2026-08-0611:25 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001819790-26-000064 |
| 2026-08-0611:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-26-000063 |
| 2026-08-0611:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001819790-26-000062 |
| 2026-08-0611:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001819790-26-000060 |
| 2026-07-1320:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001819790-26-000048 |
| 2026-07-0820:13 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001819790-26-000046 |
| 2026-06-2920:19 ET | 8-K | 5.07 Shareholder vote results | 0001819790-26-000043 |
| 2026-05-0620:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001819790-26-000038 |
| 2026-05-0620:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-26-000037 |
| 2026-04-2820:09 ET | DEF 14A | Proxy statementPeriod 2026-06-25 | 0001819790-26-000028 |
| 2026-02-2321:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001819790-26-000019 |
| 2026-02-2321:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-26-000017 |
| 2026-02-1813:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001819790-26-000005 |
| 2026-01-1213:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001819790-26-000002 |
| 2025-11-0421:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001819790-25-000121 |
| 2025-11-0421:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-25-000120 |
| 2025-08-0620:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001819790-25-000108 |
| 2025-08-0620:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-25-000107 |
| 2025-06-1820:05 ET | 8-K | 5.07 Shareholder vote results | 0001819790-25-000100 |
| 2025-05-0120:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001819790-25-000078 |
| 2025-05-0120:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-25-000077 |
| 2025-04-2820:04 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001819790-25-000070 |
| 2025-03-1820:01 ET | 8-K | 8.01 Other events | 0001819790-25-000035 |
| 2025-03-1320:40 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-053978 |
| 2025-02-2521:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001819790-25-000011 |
| 2025-02-2512:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-25-000007 |
| 2025-01-1722:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001819790-25-000003 |
| 2025-01-1313:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005030 |
| 2024-12-1922:03 ET | 8-K | 1.01 Entry into a material agreement | 0001819790-24-000138 |
| 2024-11-1321:12 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001819790-24-000129 |
| 2024-11-1321:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-24-000127 |
| 2024-11-0521:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001819790-24-000119 |
| 2024-08-0820:13 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001819790-24-000111 |
| 2024-08-0820:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-24-000109 |
| 2024-06-1820:26 ET | 8-K | 5.07 Shareholder vote results | 0001819790-24-000087 |
| 2024-05-0820:12 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001819790-24-000063 |
| 2024-05-0820:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-24-000062 |
| 2024-04-2620:24 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001819790-24-000056 |
| 2024-04-2312:34 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001819790-24-000050 |
| 2024-03-0521:09 ET | 8-K | 8.01 Other events | 0001819790-24-000024 |
| 2024-03-0122:26 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-056209 |
| 2024-02-2721:02 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001819790-24-000018 |
| 2024-02-2702:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-24-000015 |
| 2024-01-1821:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001819790-24-000006 |
| 2024-01-0814:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001819790-24-000004 |
| 2023-12-1114:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001819790-23-000088 |
| 2023-11-0921:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-23-000081 |
| 2023-11-0921:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001819790-23-000080 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.